SEARCH

SEARCH BY CITATION

References

  • 1
    Attili AF, Carulli N, Roda E, Barbara L, Capocaccia L, Menotti A, Okolic-sanyi L, et al. Epidemiology of gallstone disease in Italy: prevalence data of the multicenter Italian study on cholelithiasis (M. I. COL.). Am J Epidemiol 1995; 141: 158165.
  • 2
    Rome Group for the Epidemiology and Prevention of Cholelithiasis. The epidemiology of gallstone disease in Rome, Italy, Part I. Prevalence data in men. Hepatology 1988; 8: 904906.
  • 3
    Rome Group for the Epidemiology and Prevention of Cholelithiasis. Prevalence of gallstone disease in an Italian adult female population. Am J Epidemiol 1984; 119: 796805.
  • 4
    Rome Group for the Epidemiology and Prevention of Cholelithiasis. Epidemiology of gallstone disease in Italy: comparison between a rural and urban female population. Ital J Gastroenterol 1987; 19: 129133.
  • 5
    Rome Group for the Epidemiology and Prevention of Cholelithiasis. The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). Hepatology 1988; 8: 907913.
  • 6
    Barbara L, Sama C, Labate AM Morselli, Taroni F, Rusticali AG, Festi D, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology 1987; 7: 913917.
  • 7
    Festi D, Lalloni L, Taroni F, Barbara L, Menotti A, Ricci G, and the MICOL study group. Inter and intra-observer variation in ultrasono-graphic detection of gallstones: the Multicenter Italian study on epidemiology of cholelithiasis (M. I. COL.). Eur J Epidemiol 1989; 5: 5157.
  • 8
    the MICOL group Prevalence of gallstone disease in 18 Italian population samples: first results from the MICOL study. In: CapocacciaL, RicciG, AngelicoF, AngelicoM, AttiliAF, LalloniL, eds. Recent Advances in the Epidemiology and Prevention of Gallstone Disease. Dordrecht: Kluwer, 1991: 3744.
  • 9
    Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology 1990; 99: 843849.
  • 10
    Jorgensen T. Gallstones and plasma lipids in a Danish population. Scand J Gastroenterol 1989; 24: 916922.
  • 11
    Shinchi K, Kono S, Honjo S, Imanishi K, Hirohata T. Serum lipids and gallstone disease. A study of self-defense officials in Japan. Ann Epidemiol 1993; 3: 614618.
  • 12
    Friedman GD, Kamel WB, Dawber TR. The epidemiology of gallbladder disease: observation in the Framingham study. J Chron Dis 1966; 19: 273292.
  • 13
    Diehl AK, Stern MP, Ostrower VS, Friedman PC. Prevalence of clinical gallbladder disease in Mexican-American, Anglo, and black women. South Med J 1980; 73: 438441, 443.
  • 14
    Friedman GD, Petitti DB, Klatsky AL. Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol. N Engl J Med 1981; 304: 13941398.
  • 15
    Scragg RKR, Calvert GD, Oliver JR. Plasma lipids and insulin in gall stone disease: a case-control study. Br Med J 1984; 289: 521525.
  • 16
    Maurer KR, Everhart JE, Knowler WC, Shawker TH, Roth HP. Risk factors for gallstone disease in the Hispanic populations of the United States. Am J Epidemiol 1990; 131: 836844.
  • 17
    Diehl AK, Rosenthal M, Hazuda HP, Comeaux PJ, Stern MP. Socioeconomic status and the prevalence of clinical gallbladder disease. J Chron Dis 1985; 38: 10191026.
  • 18
    Diehl AK, Haffner SM, Hazuda HP, Stern MP. Coronary risk factors and clinical gallbladder disease: an approach to the prevention of gallstones? Am J Public Health 1987; 77: 841845.
  • 19
    Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992; 55: 652658.
  • 20
    Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man. N Engl J Med 1978; 299: 11611167.
  • 21
    Shiffman ML, Sugerman HJ, Kellum JH, Brewer WH, Moore EW. Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes 1993; 17: 153158.
  • 22
    Yang H, Petersen GM, Roth MP, Schoenfield LJ, Marks JW. Risk factors for gallstone formation during rapid loss of weight. Dig Dis Sci 1992; 37: 912918.
  • 23
    Shiffman ML, Sugerman HJ, Kellum JM, Brewer WH, Moore EW. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 1991; 86: 10001005.
  • 24
    Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, Marks JW. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight [Comments]. N Engl J Med 1988; 319: 15671572.
  • 25
    Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 1993; 119: 10291035.
  • 26
    Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol 1993; 88: 17051710.
  • 27
    Hofmann AF. Primary and secondary prevention of gallstone disease: implications for patient management and research priorities. Am J Surg 1993; 165: 541548.
  • 28
    Shiffman ML, Sugerman HJ, Kellum JH, Brewer WH, Moore EW. Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes 1993; 17: 153158.
  • 29
    Marks JW, Stein T, Schoenfield LJ. Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man. Dig Dis Sci 1994; 39: 19811984.
  • 30
    Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med 1995; 98: 115117.
  • 31
    Kurata JH, Marks JW, Abbey D. One gram of aspirin per day does not reduce risk of hospitalization for gallstone disease. Dig Dis Sci 1991; 36: 11101115.
  • 32
    Kupfer RM, Northfield TC. Effect of sodium acetyl salicylate on cholesterol saturation of fasting gall bladder bile, with and without chenic acid. Br J Clin Pharmacol 1983; 15: 114116.
  • 33
    Cohen BI, Mosbach EH, Ayyad N, Yoshii M, McSherry CK. Aspirin does not inhibit cholesterol cholelithiasis in two established animal models. Gastroenterology 1991; 101: 11091116.
  • 34
    Lee SP, Carey MC, LaMont JT. Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 1981; 211: 14291431.
  • 35
    Sahlin S, Ahlberg J, Einarsson K, Danielsson A. The effect of aspirin on gallbladder epithelium and bile composition in patients with gallstones. Eur J Gastroenterol Hepatol 1992; 4: 10191024.
  • 36
    Das A, Baijal SS, Saraswat VA. Effect of aspirin on gallbladder motility in patients with gallstone disease. Dig Dis Sci 1995; 40: 17821785.
  • 37
    Hood K, Gleeson D, Ruppin DC, Dowling RH. Prevention of gallstone recurrence by non-steroidal anti-inflammatory drugs. Lancet 1988; 2: 12231225.
  • 38
    Bateson MC, Maclean D, Ross PE, Bouchier IAD. Clofibrate therapy and gallstone induction. Am J Dig Dis 1978; 23: 623628.
  • 39
    Braverman DZ, Johnson ML, Kern FJ. Effects of pregnancy and contraceptive steroids on gallbladder function. N Engl J Med 1980; 302: 362364.
  • 40
    Strom BL, Tamragouri RN, Morse ML, Lazar EL, West SL, Strolley PD, Jones JK. Oral contraceptives and other risk factors for gallbladder disease. Clin Pharmacol Ther 1986; 39: 335341.
  • 41
    Jarnfelt-Sampsioe A, Eriksson B, Leissner KH, Samsioe G. Gallbladder disease related to use of oral contraceptives and nausea in pregnancy. Southern Med J 1985; 78: 10401043.
  • 42
    Everson GT, McKinley C, Lawson M, Johnson M, Kern F, Jr. Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology 1982; 82: 811819.
  • 43
    Evron S, Frankel M, Diamant Y. Biliary disease in young women and its association with pregnancy or oral contraceptives. Int Surg 1982; 67: 448450.
  • 44
    Di Padova C, Campana ZG, Podda M. Cholesterol supersaturation of bile in women during oral contraceptive use. Ital J Gastroenterol 1978; 10: 6263.
  • 45
    Grodstein F, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ. A prospective study of symptomatic gallstones in women: relation with oral contraceptives and other risk factors. Obstet Gynecol 1994; 84: 207214.
  • 46
    Thijs C, Leffers P, Knipschild P. Oral contraceptive use and the occurrence of gallstone disease–a case-control study. Prev Med 1993; 22: 122131.
  • 47
    Bennion LJ, Mott DM, Howard BV. Oral contraceptives raise the cholesterol saturation of bile by increasing biliary cholesterol secretion. Metabolism 1980; 29: 1822.
  • 48
    Van der Werf SD, Van Berge Henegouwen GP, Ruben AT, Palsma DM. Biliary lipids, bile acid metabolism, gallbladder motor function and small intestinal transit during ingestion of a sub-fifty oral contraceptive. J Hepatol 1987; 4: 318326.
  • 49
    Petitti DB, Sidney S, Perlman JA. Increased risk of cholecystectomy in users of supplemental estrogen. Gastroenterology 1988; 94: 9195.
  • 50
    Kern F, Jr., Everson GT, DeMark B, McKinley C, Showalter R, Braver-man DZ, van Leeuven P Szczepanik, et al. Biliary lip ids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids. J Lab Clin Med 1982: 99: 798805.
  • 51
    Thijs C, Knipschild P. Oral contraceptives and the risk of gallbladder disease: a meta-analysis. Am J Public Health 1993; 83: 11131120.
  • 52
    Hanis CL, Hewett-Emmett D, Kubrusly LF, Maklad MN, Douglas TC, Mueller WH, Barton SA, et al. An ultrasound survey of gallbladder disease among Mexican Americans in Starr County, Texas: frequencies and risk factors. Ethn Dis 1993; 3: 3243.
  • 53
    Rahman HA Abdel, Hafez AS, Maymoun NM, el Gendy SD, Abdo AS, Yonis AM, Aziz S. Abdel Risk factors of gallstone disease in a sample of patients in Benha City. J Egypt Public Health Assoc 1993; 68: 205227.
  • 54
    Fornari F, Imberti D, Squillante MM, Squassante L, Civardi G, Buscarini E, Cavanna L, et al. Incidence of gallstones in a population of patients with cirrhosis. J Hepatol 1994: 20: 797801.
  • 55
    Conte D, Barisani D, Mandelli C, Bodini P, Borzio M, Pistoso S, Segala M, et al. Cholelithiasis in cirrhosis: analysis of 500 cases. Am J Gastroenterol 1991; 86: 16291632.
  • 56
    Acalovschi M, Badea R, Pascu M. Incidence of gallstones in liver cirrhosis. Am J Gastroenterol 1991; 86: 11791181.
  • 57
    La Vecchia C, Negri E, D'Avanzo B, Franceschi S, Boyle P. Risk factors for gallstone disease requiring surgery. Int J Epidemiol 1991; 20: 209215.
  • 58
    Fornari F, Civardi G, Buscarini E, Cavanna L, Imberti D, Rossi S, Sholli G, et al. Cirrhosis of the liver. A risk factor for development of cholelithiasis in men. Dig Dis Sci 1990; 35: 14031408.
  • 59
    Schwesinger WH, Kurtin WE, Levine BA, Page CP. Cirrhosis and alcoholism as pathogenetic factors in pigment gallstone formation. Ann Surg 1985; 201: 319322.
  • 60
    Acalovschi M, Badea R, Dumitrascu D, Varga C. Prevalence of gallstones in liver cirrhosis: a sonographic survey. Am J Gastroenterol 1988; 83: 954956.
  • 61
    Iber FL, Caruso G, Polepalle C, Kuchipudi V, Chinoy M. Increasing prevalence of gallstones in male veterans with alcoholic cirrhosis. Am J Gastroenterol 1990; 85: 15931596.
  • 62
    Soloway RD, Trotman BW, Maddrey WC, Nakayama F. Pigment gallstone composition in patients with hemolysis or infection/stasis. Dig Dis Sci 1986; 31: 454460.